New radiation approach targets liver tumors without surgery

NCT ID NCT03408665

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a precise type of radiation called SBRT for people with liver cancer or tumors that have spread to the liver. It includes 280 participants with various liver tumor types. The goal is to see how well SBRT controls tumor growth and what side effects occur.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

SBRT (stereotactic body radiation therapy)

What this could lead to

If successful, this could provide a non-invasive treatment option to control liver tumors and delay progression.

What could go wrong

This is a phase II study, so results are preliminary. The treatment may not improve survival or could cause side effects like liver damage.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LIVER CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cholangiocarcinoma hepatocellular carcinoma liver cancer Liver Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Centre Léonard de Vinci

    Dechy, France

  • Centre Oscar Lambret

    Lille, Nord, 59020, France

  • Centre Paul Strauss

    Strasbourg, France

  • Institut Gustave Roussy

    Villejuif, 94800, France

  • Institut Régional du Cancer de Montpellier

    Montpellier, France

  • Institut de Cancérologie Paris Nord

    Sarcelles, 95200, France

  • Institut de Cancérologie de Lorraine

    Vandœuvre-lès-Nancy, 54519, France